Original: Clinical trials with ALS patients showed that Riluzole lengthens survival by several months, and may have a greater survival benefit for those with a bulbar onset.
Simplified: Clinical trials with ALS patients showed that riluzole gives a better chance of survival by several months, mainly in those with a hard time swallowing.